Gefzest Gefitinib 250mg Tablets

250mg Tablets, Box

4.5 (154)

₹2,300

Gefzest 250mg Tablet is used to treat non-small cell lung cancer, particularly in patients where it has spread, with abnormal EGFR gene mutations, and no prior cancer treatment. It works by blocking an abnormal protein that signals cancer cells to multiply, helping stop or slow cancer spread. It should be taken consistently at the same time each day, avoiding alcohol and staying well-hydrated during treatment. It may take several weeks or months to see the full benefits.

Description

Introduction Of Gefzest Gefitinib 250mg Tablets:

Gefzest 250mg Tablet is used in the treatment of non-small cell lung cancer. It is used in patients whose disease has spread to other parts of the body, who have specific EGFR gene mutations, and who have not received prior treatment for the disease.

Gefzest 250mg Tablet can be taken with or without food, but it’s best to take it at the same time each day for improved results. You should continue taking it for as long as your doctor advises. The length of treatment varies based on your individual response. You should take it exactly as your doctor has advised. Using it incorrectly or taking too much can cause severe side effects. It might require a little while or months for you to see or feel the advantages however don’t quit taking it except if your doctor tells you to.

Uses Of Gefzest 250mg:

  • Non-little cell cellular breakdown in the lungs

Benefits Of Gefzest 250mg:

In Non-little cell cellular breakdown in the lungs

Non-small cell lung cancer is one of the major types of lung cancer and affects both smokers and non-smokers. Gefzest 250mg Tablet helps treat non-small cell lung cancer and may be given alone or in combination with other medicines. It is a potent medication with significant risks, and you should discuss the risks and benefits with your doctor. You should avoid drinking alcohol while having this treatment, and drink plenty of water to stay hydrated.

Mechanism Of Action Of Gefzest 250mg:

Gefzest 250mg Tablet is an anticancer medicine. It works by blocking the activity of an abnormal protein that signals cancer cells to multiply. This helps stop or slow the spread of cancer cells.

Contact Us

Info Table
Packaging Size Strip
Brand Gefzest 250MG
Composition Geftinib 250mg
Manufacturer United Biotech Pvt Ltd
Treatment Non-small cell lung cancer
Prescription/Non prescription Prescription
Vendor Info
Benefits
Reviews

Description

Introduction Of Gefzest Gefitinib 250mg Tablets:

Gefzest 250mg Tablet is used in the treatment of non-small cell lung cancer. It is used in patients whose disease has spread to other parts of the body, who have specific EGFR gene mutations, and who have not received prior treatment for the disease.

Gefzest 250mg Tablet can be taken with or without food, but it’s best to take it at the same time each day for improved results. You should continue taking it for as long as your doctor advises. The length of treatment varies based on your individual response. You should take it exactly as your doctor has advised. Using it incorrectly or taking too much can cause severe side effects. It might require a little while or months for you to see or feel the advantages however don’t quit taking it except if your doctor tells you to.

Uses Of Gefzest 250mg:

  • Non-little cell cellular breakdown in the lungs

Benefits Of Gefzest 250mg:

In Non-little cell cellular breakdown in the lungs

Non-small cell lung cancer is one of the major types of lung cancer and affects both smokers and non-smokers. Gefzest 250mg Tablet helps treat non-small cell lung cancer and may be given alone or in combination with other medicines. It is a potent medication with significant risks, and you should discuss the risks and benefits with your doctor. You should avoid drinking alcohol while having this treatment, and drink plenty of water to stay hydrated.

Mechanism Of Action Of Gefzest 250mg:

Gefzest 250mg Tablet is an anticancer medicine. It works by blocking the activity of an abnormal protein that signals cancer cells to multiply. This helps stop or slow the spread of cancer cells.

Contact Us

Reviews

There are no reviews yet.

Be the first to review “Gefzest Gefitinib 250mg Tablets”

Your email address will not be published. Required fields are marked *

Frequently Asked Questions

From sourcing to delivery, we ensure reliability at every step. Our operations follow strict quality and regulatory standards.

What is Gefzest 250mg Tablet used for?
Gefitinib treats metastatic non-small cell lung cancer (NSCLC) in patients whose tumors carry specific EGFR gene mutations, confirmed by an FDA-approved test — it’s approved as a first-line treatment for these patients, not for lung cancer generally or for EGFR mutations outside the specific types tested for.
Take one tablet daily, with or without food, at a consistent time. Continue as long as your doctor advises — it may take weeks to months to see benefit, and treatment typically continues until disease progression or unacceptable side effects.
Report any new or worsening breathing problems — shortness of breath, cough, or fever — to your doctor immediately. These can indicate interstitial lung disease (ILD), a rare but potentially fatal lung inflammation linked to this drug. It’s easy to mistake these symptoms for the cancer itself, which is exactly why prompt reporting matters.
It can cause liver inflammation (watch for jaundice, dark urine, pale stools, or right-side abdominal pain), severe diarrhea, eye problems including keratitis (report eye pain, redness, or vision changes), and rare but serious skin reactions. Regular liver function testing is recommended throughout treatment.
Skin reactions (rash, dry skin) and diarrhea are most common, occurring in more than 20% of patients. Staying hydrated and discussing skin care with your doctor can help manage these.
Yes, but with real interactions to flag: acid-reducing drugs like proton pump inhibitors can lower Gefzest’s effectiveness and should generally be avoided; strong CYP3A4-inducing drugs may require a dose increase; and combining with warfarin requires closer monitoring due to bleeding risk. Disclose all medications to your oncologist before starting.

Related products